Henan Xintiandi Pharmaceutical Co was established in 2005 with a registered capital of 99 million yuan, the existing assets of 300 million yuan. and is mainly engaged in pharmaceutical intermediates, fine chemicals R & D, production and sales.

 

Our leading products Hydroxyphenylglycine L, L-hydroxyphenylglycine Deng salt of Science and Technology Department of Henan Province have been identified as high-tech products, the project was included in the first and second batch of high-tech industrialization projects Henan provincial government. Our company is the first domestic development and production of L and its derivatives Hydroxyphenylglycine manufacturers, products of the technical quality indicators have reached the international advanced level.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

4-acetoxystyrene

HENAN NEWLAND PHARMACEUTICAL CO.,LTD

D-hydroxyphenylglycine

HENAN NEWLAND PHARMACEUTICAL CO.,LTD

L-hydroxyphenylglycine

HENAN NEWLAND PHARMACEUTICAL CO.,LTD

Categories affiliated with HENAN NEWLAND PHARMACEUTICAL CO.,LTD